STSA Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Benzinga - Mentions: APRE ERAS

Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying

3 years ago - By: Satsuma Pharmaceuticals

Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101, a Novel and Investigational Dihydroergotamine (DHE) Nasal Powder Product for the Acute Treatment of Migraine

3 years ago - By: Halper Sadeh LLP - Mentions: MGTA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA

3 years ago - By: Kahn Swick & Foti, LLC

SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA

3 years ago - By: InvestorPlace - Mentions: MRAI RXDX

Why Is Marpai (MRAI) Stock Down 40% Today?

3 years ago - By: InvestorPlace - Mentions: LAZR

Why Is Satsuma Pharmaceuticals (STSA) Stock Up 144% Today?

3 years ago - By: Halper Sadeh LLP - Mentions: TESS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TESS, STSA, CHRA

3 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Satsuma Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Shin Nippon

3 years ago - By: Kahn Swick & Foti, LLC

SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA

3 years ago - By: Satsuma Pharmaceuticals

SNBL to Acquire Satsuma Pharmaceuticals

3 years ago - By: Benzinga - Mentions: NRBO OTIC DBVT AYTU ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

3 years ago - By: Satsuma Pharmaceuticals

Satsuma Pharmaceuticals Announces Three Abstracts Accepted at The 75th American Academy of Neurology Annual Meeting

3 years ago - By: Halper Sadeh LLP - Mentions: RXDX

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates RXDX, STSA, CHRA

3 years ago - By: Halper Sadeh LLC

STSA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Satsuma Pharmaceuticals, Inc. Is Fair to Shareholders

3 years ago - By: InvestorPlace - Mentions: SAI RXDX MRAI

Why Is SAI.TECH Global (SAI) Stock Down 32% Today?

3 years ago - By: InvestorPlace - Mentions: RXDX MRK

Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?

3 years ago - By: InvestorPlace - Mentions: CFRX RXDX MRK CNSP ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

3 years ago - By: Satsuma Pharmaceuticals

Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights

3 years ago - By: Satsuma Pharmaceuticals

Satsuma Pharmaceuticals to Participate in the Virtual SVB Securities Global Biopharma Conference

3 years ago - By: Satsuma Pharmaceuticals

Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update

3 years ago - By: Satsuma Pharmaceuticals

Satsuma Pharmaceuticals Inc (STSA) Stock News

STSA Latest News, Press Relases and Analysis

Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying

Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101, a Novel and Investigational Dihydroergotamine (DHE) Nasal Powder Product for the Acute Treatment of Migraine

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA

SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA

Why Is Marpai (MRAI) Stock Down 40% Today?

Why Is Satsuma Pharmaceuticals (STSA) Stock Up 144% Today?

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TESS, STSA, CHRA

Shareholder Alert: Ademi LLP investigates whether Satsuma Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Shin Nippon

SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA

SNBL to Acquire Satsuma Pharmaceuticals

12 Health Care Stocks Moving In Monday's Pre-Market Session

Satsuma Pharmaceuticals Announces Three Abstracts Accepted at The 75th American Academy of Neurology Annual Meeting

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates RXDX, STSA, CHRA

STSA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Satsuma Pharmaceuticals, Inc. Is Fair to Shareholders

Why Is SAI.TECH Global (SAI) Stock Down 32% Today?

Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights

Satsuma Pharmaceuticals to Participate in the Virtual SVB Securities Global Biopharma Conference

Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update

Satsuma Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference